Scientists uncover hints of a potential new cause of stomach cancer

For the first time, scientists have systematically analyzed somatic mutations in stomach lining tissue to unpick mutational processes, some of which can lead to cancer.

Exclusive: Backed by MIT’s Andrew Lo, Quantile Health raises $6M to bolster gene therapy access

In a bid to overcome some of the commercial challenges faced by expensive new gene therapies, Quantile Health has raised $6 million for a financial

March 2, 2024

Lexicon to face FDA AdComm for Zynquista approval in diabetes and CKD

In 2019, the FDA declined to approve Lexicon’s Zynquista as an adjunct to insulin in type 1 diabetes, citing safety concerns following a split 8-8

August 22, 2024

Berlin Cures announces changes to Board of Directors to further propel the development of BC 007 – Biotech Investments

Issuer: Berlin Cures Holding AG / Key word(s): Personnel 26.06.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.